Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

0.0%

0 terminated out of 22 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

41%

7 of 17 completed with results

Key Signals

7 with results100% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (7)
Early P 1 (1)
P 1 (1)
P 2 (3)
P 3 (3)

Trial Status

Completed17
Recruiting2
Unknown2
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT00887939CompletedPrimary

Pathogenesis of Physical Induced Urticarial Syndromes

NCT07400718Not ApplicableCompleted

Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test Applicators

NCT03563066Phase 2Completed

Effect of Benralizumab in Atopic Dermatitis

NCT06755281Not ApplicableRecruiting

Risk-stratified Testing for Safe Removal of Penicillin Allergy Labels

NCT05420935Not ApplicableRecruitingPrimary

Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating Room

NCT06538129Not ApplicableNot Yet Recruiting

Assessment of Er:YAG Laser for the Control of Hypersensitivity During Tooth Whitening With Hydrogen Peroxide

NCT05661812CompletedPrimary

Norwegian Birch Rust Allergy Study

NCT04454229Not ApplicableCompletedPrimary

The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge

NCT03688074Phase 2Completed

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

NCT03627767Phase 3Completed

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

NCT02162576Not ApplicableCompleted

Asthma Data Innovation Demonstration Project

NCT04322838UnknownPrimary

Tromsø Birch Rust Allergy Study. Allergy to Birch Rust, a Possible Explanation to Seasonal Airway Allergy During Autumn?

NCT03720470Phase 3Completed

Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

NCT03918772CompletedPrimary

Clinical Determinants and Perioperative Allergic Reactions (CADECAP Study)

NCT02503800CompletedPrimary

The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy

NCT03054428Phase 3Completed

Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis

NCT01904604Phase 2Completed

Peanut Epicutaneous Phase II Immunotherapy Clinical Trial

NCT02916888Completed

A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists

NCT02163122Early Phase 1CompletedPrimary

Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)

NCT00102570CompletedPrimary

Clinical and Immunological Evaluation of Children With Allergies

Scroll to load more

Research Network

Activity Timeline